Search Ontology:
ChEBI
alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp
- Term ID
- CHEBI:140999
- Synonyms
-
- (2R,3R,4S,5S,6R)-2-{[(2R,3S,4R,5R,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-{[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
- alpha-D-Glc-(1->4)-alpha-D-Glc-(1->4)-D-Glc
- alpha-D-glucopyranosyl-(1->4)-alpha-D-glucopyranosyl-(1->4)-D-glucopyranose
- alpha-D-glucosyl-(1->4)-alpha-D-glucosyl-(1->4)-D-glucoose
- amylotriose
- Glcalpha1-4Glcalpha1-4Glc
- maltotriose
- WURCS=2.0/2,3,2/[a2122h-1x_1-5][a2122h-1a_1-5]/1-2-2/a4-b1_b4-c1
- Definition
- A maltotriose trisaccharide in which the glucose residue at the reducing end is in the pyranose form.
- References
-
- GlyGen:G33575EC
- GlyTouCan:G33575EC
- KEGG:G00280
- PMID:29610143
- Reaxys:1443481
- Ontology
- ChEBI ( EBI )
- is a type of
-
- inverse has_functional_parent
-
Phenotype
Phenotype resulting from alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp
Phenotype where environments contain alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp
Phenotype modified by environments containing alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp
Human Disease Model